| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)
|
LeCaer, H.
|
|
2012
|
77 |
1 |
p. 97-103
7 p.
|
artikel
|
| 2 |
A phase I/II study of carboplatin plus gemcitabine for elderly patients with advanced non-small cell lung cancer: West Japan Thoracic Oncology Group Trial (WJTOG) 2905
|
Kurata, Takayasu
|
|
2012
|
77 |
1 |
p. 110-115
6 p.
|
artikel
|
| 3 |
Applying Best–Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer
|
Molassiotis, Alex
|
|
2012
|
77 |
1 |
p. 199-204
6 p.
|
artikel
|
| 4 |
Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: A meta-analysis
|
Zhang, Hai-Long
|
|
2012
|
77 |
1 |
p. 9-15
7 p.
|
artikel
|
| 5 |
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
|
Umemura, Shigeki
|
|
2012
|
77 |
1 |
p. 134-139
6 p.
|
artikel
|
| 6 |
Contents
|
|
|
2012
|
77 |
1 |
p. vii-ix
nvt p.
|
artikel
|
| 7 |
Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues
|
Hirota, Takeshi
|
|
2012
|
77 |
1 |
p. 16-23
8 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2012
|
77 |
1 |
p. v-
1 p.
|
artikel
|
| 9 |
EGFR–TKI resistant non-small cell lung cancer (NSCLC): New developments and implications for future treatment
|
Brugger, Wolfram
|
|
2012
|
77 |
1 |
p. 2-8
7 p.
|
artikel
|
| 10 |
Emphysema detected on computed tomography and risk of lung cancer: A systematic review and meta-analysis
|
Smith, Benjamin M.
|
|
2012
|
77 |
1 |
p. 58-63
6 p.
|
artikel
|
| 11 |
Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)
|
Cedrés, S.
|
|
2012
|
77 |
1 |
p. 192-198
7 p.
|
artikel
|
| 12 |
Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
|
Degese, María S.
|
|
2012
|
77 |
1 |
p. 168-175
8 p.
|
artikel
|
| 13 |
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure
|
Rena, Ottavio
|
|
2012
|
77 |
1 |
p. 151-155
5 p.
|
artikel
|
| 14 |
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing
|
Basseres, Daniela S.
|
|
2012
|
77 |
1 |
p. 31-37
7 p.
|
artikel
|
| 15 |
Generalisability of the results of the Dutch–Belgian randomised controlled lung cancer CT screening trial (NELSON): Does self-selection play a role?
|
van der Aalst, C.M.
|
|
2012
|
77 |
1 |
p. 51-57
7 p.
|
artikel
|
| 16 |
Health-related quality of life in patients with lung cancer: Validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire
|
Arrieta, Óscar
|
|
2012
|
77 |
1 |
p. 205-211
7 p.
|
artikel
|
| 17 |
Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: Mechanism for immune evasion?
|
Soriano, Cyd
|
|
2012
|
77 |
1 |
p. 38-45
8 p.
|
artikel
|
| 18 |
In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling
|
Santonico, M.
|
|
2012
|
77 |
1 |
p. 46-50
5 p.
|
artikel
|
| 19 |
Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features
|
Sekine, Akimasa
|
|
2012
|
77 |
1 |
p. 64-69
6 p.
|
artikel
|
| 20 |
Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer
|
Iochmann, Sophie
|
|
2012
|
77 |
1 |
p. 70-76
7 p.
|
artikel
|
| 21 |
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung
|
Lee, Jin Gu
|
|
2012
|
77 |
1 |
p. 156-161
6 p.
|
artikel
|
| 22 |
Oncologists’ assessments of lung cancer patient and family disagreements regarding treatment decision making
|
Siminoff, Laura A.
|
|
2012
|
77 |
1 |
p. 212-216
5 p.
|
artikel
|
| 23 |
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group
|
Mountzios, Giannis
|
|
2012
|
77 |
1 |
p. 146-150
5 p.
|
artikel
|
| 24 |
Patients’ preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
|
Bridges, John F.P.
|
|
2012
|
77 |
1 |
p. 224-231
8 p.
|
artikel
|
| 25 |
Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer
|
Mir, Olivier
|
|
2012
|
77 |
1 |
p. 104-109
6 p.
|
artikel
|
| 26 |
Perineal and colonic metastases in two cases of malignant mesothelioma
|
Grewal, Bhajneek
|
|
2012
|
77 |
1 |
p. 235-238
4 p.
|
artikel
|
| 27 |
Primum non nocere? Does this also apply to mesothelioma?
|
Baas, Paul
|
|
2012
|
77 |
1 |
p. 1-
1 p.
|
artikel
|
| 28 |
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
|
Shien, Kazuhiko
|
|
2012
|
77 |
1 |
p. 162-167
6 p.
|
artikel
|
| 29 |
Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: External validation in a phase III trial comparing vinflunine with docetaxel
|
Di Maio, Massimo
|
|
2012
|
77 |
1 |
p. 116-120
5 p.
|
artikel
|
| 30 |
Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC)
|
Liu, Yi-Zhen
|
|
2012
|
77 |
1 |
p. 176-182
7 p.
|
artikel
|
| 31 |
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer
|
Wang, Luhua
|
|
2012
|
77 |
1 |
p. 89-96
8 p.
|
artikel
|
| 32 |
Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: A potential modality for inducing long-term survival in selected patients
|
Ohguri, Takayuki
|
|
2012
|
77 |
1 |
p. 140-145
6 p.
|
artikel
|
| 33 |
Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study
|
Oh, In-Jae
|
|
2012
|
77 |
1 |
p. 121-127
7 p.
|
artikel
|
| 34 |
Retrospective study of erlotinib in patients with advanced squamous lung cancer
|
Tseng, Jeng-Sen
|
|
2012
|
77 |
1 |
p. 128-133
6 p.
|
artikel
|
| 35 |
shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis
|
Meng, Xiuxiang
|
|
2012
|
77 |
1 |
p. 24-30
7 p.
|
artikel
|
| 36 |
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors
|
Rausch, Sarah M.
|
|
2012
|
77 |
1 |
p. 217-223
7 p.
|
artikel
|
| 37 |
Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer
|
Takeda, Atsuya
|
|
2012
|
77 |
1 |
p. 77-82
6 p.
|
artikel
|
| 38 |
The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)
|
Gottschling, Sandra
|
|
2012
|
77 |
1 |
p. 183-191
9 p.
|
artikel
|
| 39 |
Thymoma and solid-organ transplantation
|
Guibert, Nicolas
|
|
2012
|
77 |
1 |
p. 232-234
3 p.
|
artikel
|
| 40 |
Verification of beam delivery using fibrosis after proton beam irradiation to the lung tumor
|
Fukumitsu, Nobuyoshi
|
|
2012
|
77 |
1 |
p. 83-88
6 p.
|
artikel
|
Tijdschrift beschrijving